Molecular pathology of the FSH receptor: New insights into FSH physiology

Molecular and Cellular Endocrinology

Volumn 282, Issue 1-2, 2008, Pages 130-142

  Meduri, G ^a,b   Bachelot, A ^c   Cocca, M P ^d   Vasseur, C ^e   Rodien, P ^e,f   Kuttenn, F ^c   Touraine, P ^c   Misrahi, M ^a,b  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^b BICÊTRE HOSPITAL   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^d UNIVERSITY OF BARI   (Italy)

^e ANGERS UNIVERSITY HOSPITAL   (France)

^f INSERM   (France)

Author keywords

Deficient mice; FSH receptor; G protein coupled receptor; Genetics; Gonadotropin; Mutation; Ovarian follicle; Ovarian hyperstimulation syndrome; Premature ovarian failure

Indexed keywords

FOLLITROPIN RECEPTOR; RECOMBINANT FOLLITROPIN;

ARTICLE; CLINICAL FEATURE; FEMALE FERTILITY; FERTILIZATION IN VITRO; GENETIC ANALYSIS; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOHISTOLOGY; MALE FERTILITY; MUTATIONAL ANALYSIS; NONHUMAN; OVARY HYPERSTIMULATION; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PUBERTY; SPERMATOGENESIS;

ANIMALS; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; INFERTILITY, FEMALE; INFERTILITY, MALE; MALE; MICE; MUTATION; OVARIAN HYPERSTIMULATION SYNDROME; PEDIGREE; RECEPTORS, FSH;

EID: 39149116712     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2007.11.027     Document Type: Article

References (88)

1. Abel M.H., Wootton A.N., Wilkins V., Huhtaniemi I., Knight P.G., and Charlton H.M. The effect of a null mutation in the follicle-stimulating hormone receptor gene on mouse reproduction. Endocrinology 141 (2000) 1795-1803
2. Aittomaki K., Lucena J.L., Pakarinen P., Sistonen P., Tapanainen J., Gromoll J., Kaskikari R., Sankila E.M., Lehvaslaiho H., Engel A.R., Nieschlag E., Huhtaniemi I., and de la Chapelle A. Mutation in the follicle-stimulating hormone receptor gene causes hereditary hypergonadotropic ovarian failure. Cell 82 (1995) 959-968
3. Aittomaki K., Herva R., Stenman U.H., Juntunen K., Ylostalo P., Hovatta O., and de la Chapelle A. Clinical features of primary ovarian failure caused by a point mutation in the follicle-stimulating hormone receptor gene. J. Clin. Endocrinol. Metab. 81 (1996) 3722-3726
4. Allen L.A., Achermann J.C., Pakarinen P., Kotlar T.J., Huhtaniemi I.T., Jameson J.L., Cheetham T.D., and Ball S.G. A novel loss of function mutation in exon 10 of the FSH receptor gene causing hypergonadotrophic hypogonadism: clinical and molecular characteristics. Hum. Reprod. 18 (2003) 251-256
5. Baird D. Role of FSH and LH in follicle development. J. Gynecol. Obstet. Biol. Reprod. (Paris) 35 (2006) 2S24-2S29
6. Baker P.J., Pakarinen P., Huhtaniemi I.T., Abel M.H., Charlton H.M., Kumar T.R., and O'Shaughnessy P.J. Failure of normal Leydig cell development in follicle-stimulating hormone (FSH) receptor-deficient mice, but not FSHbeta-deficient mice: role for constitutive FSH receptor activity. Endocrinology 144 (2003) 138-145
7. Beau I., Touraine P., Meduri G., Gougeon A., Desroches A., Matuchansky C., Milgrom E., Kuttenn F., and Misrahi M. A novel phenotype related to partial loss of function mutations of the follicle stimulating hormone receptor. J. Clin. Invest. 102 (1998) 1352-1359
8. Beck-Peccoz P., Persani L., Calebiro D., Bonomi M., Mannavola D., and Campi I. Syndromes of hormone resistance in the hypothalamic-pituitary-thyroid axis. Best Pract. Res. Clin. Endocrinol. Metab. 20 (2006) 529-546
9. Behre H.M., Greb R.R., Mempel A., Sonntag B., Kiesel L., Kaltwasser P., Seliger E., Ropke F., Gromoll J., Nieschlag E., and Simoni M. Significance of a common single nucleotide polymorphism in exon 10 of the follicle-stimulating hormone (FSH) receptor gene for the ovarian response to FSH: a pharmacogenetic approach to controlled ovarian hyperstimulation. Pharmacogenet. Genom. 15 (2005) 451-456
10. Block E. Quantitative morphological investigations of the follicular system in women; methods of quantitative determinations. Acta Anat. (Basel) 12 (1951) 267-285
11. Braun T., Schofield P.R., and Sprengel R. Amino-terminal leucine-rich repeats in gonadotropin receptors determine hormone selectivity. EMBO J. 10 (1991) 1885-1890
12. Budev M.M., Arroliga A.C., and Falcone T. Ovarian hyperstimulation syndrome. Crit. Care Med. 33 (2005) S301-S306
13. Burns K.H., Yan C., Kumar T.R., and Matzuk M.M. Analysis of ovarian gene expression in follicle-stimulating hormone beta knockout mice. Endocrinology 142 (2001) 2742-2751
14. Calebiro D., de Filippis T., Lucchi S., Covino C., Panigone S., Beck-Peccoz P., Dunlap D., and Persani L. Intracellular entrapment of wild-type TSH receptor by oligomerization with mutants linked to dominant TSH resistance. Hum. Mol. Genet. 14 (2005) 2991-3002
15. Campbell B.K., Souza C., Gong J., Webb R., Kendall N., Marsters P., Robinson G., Mitchell A., Telfer E.E., and Baird D.T. Domestic ruminants as models for the elucidation of the mechanisms controlling ovarian follicle development in humans. Reprod. Suppl. 61 (2003) 429-443
16. Costagliola S., Urizar E., Mendive F., and Vassart G. Specificity and promiscuity of gonadotropin receptors. Reproduction 130 (2005) 275-281
17. d'Alva C.B., Serafini P., Motta E., Latronico A.C., and Mendonca B.B. Letter re: FSH receptor polymorphisms and iatrogenic ovarian hyperstimulation. J. Clin. Endocrinol. Metab. 90 (2005) 4978 author reply 4978-9
18. Daelemans C., Smits G., de Maertelaer V., Costagliola S., Englert Y., Vassart G., and Delbaere A. Prediction of severity of symptoms in iatrogenic ovarian hyperstimulation syndrome by follicle-stimulating hormone receptor Ser680Asn polymorphism. J. Clin. Endocrinol. Metab. 89 (2004) 6310-6315
19. de Castro F., Ruiz R., Montoro L., Perez-Hernandez D., Sanchez-Casas Padilla E., Real L.M., and Ruiz A. Role of follicle-stimulating hormone receptor Ser680Asn polymorphism in the efficacy of follicle-stimulating hormone. Fertil. Steril. 80 (2003) 571-576
20. de Castro F., Moron F.J., Montoro L., Real L.M., and Ruiz A. Pharmacogenetics of controlled ovarian hyperstimulation. Pharmacogenomics 6 (2005) 629-637
21. de Koning C.H., Benjamins T., Harms P., Homburg R., van Montfrans J.M., Gromoll J., Simoni M., and Lambalk C.B. The distribution of FSH receptor isoforms is related to basal FSH levels in subfertile women with normal menstrual cycles. Hum. Reprod. 21 (2006) 443-446
22. de la Chesnaye E., Canto P., Ulloa-Aguirre A., and Mendez J.P. No evidence of mutations in the follicle-stimulating hormone receptor gene in Mexican women with 46, XX pure gonadal dysgenesis. Am. J. Med. Genet. 98 (2001) 125-128
23. De Leener A., Montanelli L., Van Durme J., Chae H., Smits G., Vassart G., and Costagliola S. Presence and absence of follicle-stimulating hormone receptor mutations provide some insights into spontaneous ovarian hyperstimulation syndrome physiopathology. J. Clin. Endocrinol. Metab. 91 (2006) 555-562
24. de Ligt R.A., Rivkees S.A., Lorenzen A., Leurs R., and IJzerman A.P. A "locked-on," constitutively active mutant of the adenosine A1 receptor. Eur. J. Pharmacol. 510 (2005) 1-8
25. Delbaere A., Smits G., Vassart G., and Costagliola S. Genetic predictors of ovarian hyperstimulation syndrome in women undergoing in vitro fertilization. Nat. Clin. Pract. Endocrinol. Metab. 2 (2006) 590-591
26. Demeestere I., Centner J., Gervy C., Englert Y., and Delbaere A. Reproduction 130 (2005) 147-156
27. Di Carlo C., Bruno P., Cirillo D., Morgera R., Pellicano M., and Nappi C. Increased concentrations of renin, aldosterone and Ca125 in a case of spontaneous, recurrent, familial, severe ovarian hyperstimulation syndrome. Hum. Reprod. 12 (1997) 2115-2117
28. Dierich A., Sairam M.R., Monaco L., Fimia G.M., Gansmuller A., LeMeur M., and Sassone-Corsi P. Impairing follicle-stimulating hormone (FSH) signaling in vivo: targeted disruption of the FSH receptor leads to aberrant gametogenesis and hormonal imbalance. Proc. Natl. Acad. Sci. U.S.A. 95 (1998) 13612-13617
29. Doherty E., Pakarinen P., Tiitinen A., Kiilavuori A., Huhtaniemi I., Forrest S., and Aittomaki K. A novel mutation in the FSH receptor inhibiting signal transduction and causing primary ovarian failure. J. Clin. Endocrinol. Metab. 87 (2002) 1151-1155
30. Eppig J.J., and O'Brien M.J. Development in vitro of mouse oocytes from primordial follicles. Biol. Reprod. 54 (1996) 197-207
31. Erickson G.F., and Shimasaki S. The physiology of folliculogenesis: the role of novel growth factors. Fertil. Steril. 76 (2001) 943-949
32. Fan Q.R., and Hendrickson W.A. Structural biology of glycoprotein hormones and their receptors. Endocrine 26 (2005) 179-188
33. Fan Q.R., and Hendrickson W.A. Structure of human follicle-stimulating hormone in complex with its receptor. Nature 433 (2005) 269-277
34. Garcia-Velasco J.A., and Pellicer A. New concepts in the understanding of the ovarian hyperstimulation syndrome. Curr. Opin. Obstet. Gynecol. 15 (2003) 251-256
35. Giacaglia L.R., Kohek M.B.d.F., Carvalho F.M., Fragoso M.C., Mendonca B., and Latronico A.C. No evidence of somatic activating mutations on gonadotropin receptor genes in sex cord stromal tumors. Fertil. Steril. 74 (2000) 992-995
36. Greb R.R., Grieshaber K., Gromoll J., Sonntag B., Nieschlag E., Kiesel L., and Simoni M. A common single nucleotide polymorphism in exon 10 of the human follicle stimulating hormone receptor is a major determinant of length and hormonal dynamics of the menstrual cycle. J. Clin. Endocrinol. Metab. 90 (2005) 4866-4872
37. Gromoll J., Simoni M., and Nieschlag E. An activating mutation of the follicle-stimulating hormone receptor autonomously sustains spermatogenesis in a hypophysectomized man. J. Clin. Endocrinol. Metab. 81 (1996) 1367-1370
38. Huhtaniemi I.T. LH and FSH receptor mutations and their effects on puberty. Horm. Res. 57 Suppl. 2 (2002) 35-38
39. Hutt K.J., and Albertini F. An oocentric view of folliculogenesis and embryogenesis. Reprod. Biomed. 14 (2007) 758-764
40. Jiang M., Aittomaki K., Nilsson C., Pakarinen P., Iitia A., Torresani T., Simonsen H., Goh V., Pettersson K., de la Chapelle A., and Huhtaniemi I. The frequency of an inactivating point mutation (566C→T) of the human follicle-stimulating hormone receptor gene in four populations using allele-specific hybridization and time-resolved fluorometry. J. Clin. Endocrinol. Metab. 83 (1998) 4338-4343
41. Kaiser U.B. The pathogenesis of the ovarian hyperstimulation syndrome. N. Engl. J. Med. 349 (2003) 729-732
42. Kopp P., van Sande J., Parma J., Duprez L., Gerber H., Joss E., Jameson J.L., Dumont J.E., and Vassart G. Brief report: congenital hyperthyroidism caused by a mutation in the thyrotropin-receptor gene. N. Engl. J. Med. 332 (1995) 150-154
43. Krishnamurthy J., Kannan K., Feng J., Mohanprasad B.K., Tsuchida N., and Shanmugam G. Mutational analysis of the candidate tumor suppressor gene ING1 in Indian oral squamous cell carcinoma. Oral Oncol. 37 (2001) 222-224
44. Kumar T.R. What have we learned about gonadotropin function from gonadotropin subunit and receptor knockout mice?. Reproduction 130 (2005) 293-302
45. Kumar T.R., Wang Y., Lu N., and Matzuk M.M. Follicle stimulating hormone is required for ovarian follicle maturation but not male fertility. Nat. Genet. 15 (1997) 201-204
46. Kumar T.R., Low M.J., and Matzuk M.M. Genetic rescue of follicle-stimulating hormone beta-deficient mice. Endocrinology 139 (1998) 3289-3295
47. Lass A., Silye R., Abrams D.C., Krausz T., Hovatta O., Margara R., and Winston R.M. Follicular density in ovarian biopsy of infertile women: a novel method to assess ovarian reserve. Hum. Reprod. 12 (1997) 1028-1031
48. Latronico A.C., Anasti J., Arnhold I.J., Rapaport R., Mendonca B.B., Bloise W., Castro M., Tsigos C., and Chrousos G.P. Brief report: testicular and ovarian resistance to luteinizing hormone caused by inactivating mutations of the luteinizing hormone-receptor gene. N. Engl. J. Med. 334 (1996) 507-512
49. Layman L.C., Porto A.L., Xie J., da Motta L.A., da Motta L.D., Weiser W., and Sluss P.M. FSH beta gene mutations in a female with partial breast development and a male sibling with normal puberty and azoospermia. J. Clin. Endocrinol. Metab. 87 (2002) 3702-3707
50. Lindstedt G., Nystrom E., Matthews C., Ernest I., Janson P.O., and Chatterjee K. Follitropin (FSH) deficiency in an infertile male due to FSHbeta gene mutation. A syndrome of normal puberty and virilization but underdeveloped testicles with azoospermia, low FSH but high lutropin and normal serum testosterone concentrations. Clin. Chem. Lab. Med. 36 (1998) 663-665
51. Lipitz S., Grisaru D., Achiron R., Ben-Baruch G., Schiff E., and Mashiach S. Spontaneous ovarian hyperstimulation mimicking an ovarian tumour. Hum. Reprod. 11 (1996) 720-721
52. Ludwig M., Gembruch U., Bauer O., and Diedrich K. Ovarian hyperstimulation syndrome (OHSS) in a spontaneous pregnancy with fetal and placental triploidy: information about the general pathophysiology of OHSS. Hum. Reprod. 13 (1998) 2082-2087
53. Magoffin D.A. Ovarian theca cell. Int. J. Biochem. Cell Biol. 37 (2005) 1344-1349
54. Meduri G., Charnaux N., Driancourt M.A., Combettes L., Granet P., Vannier B., Loosfelt H., and Milgrom E. Follicle-stimulating hormone receptors in oocytes?. J. Clin. Endocrinol. Metab. 87 (2002) 2266-2276
55. Meduri G., Touraine P., Beau I., Lahuna O., Desroches A., Vacher-Lavenu M.C., Kuttenn F., and Misrahi M. Delayed puberty and primary amenorrhea associated with a novel mutation of the human follicle-stimulating hormone receptor: clinical, histological, and molecular studies. J. Clin. Endocrinol. Metab. 88 (2003) 3491-3498
56. Meng E.C., and Bourne H.R. Receptor activation: what does the rhodopsin structure tell us?. Trends Pharmacol. Sci. 22 (2001) 587-593
57. Minegishi T., Nakamura K., Takakura Y., Ibuki Y., Igarashi M., and Minegish T. Cloning and sequencing of human FSH receptor cDNA. Biochem. Biophys. Res. Commun. 175 (1991) 1125-1130
58. Misrahi M., Meduri G., Pissard S., Bouvattier C., Beau I., Loosfelt H., Jolivet A., Rappaport R., Milgrom E., and Bougneres P. Comparison of immunocytochemical and molecular features with the phenotype in a case of incomplete male pseudohermaphroditism associated with a mutation of the luteinizing hormone receptor. J. Clin. Endocrinol. Metab. 82 (1997) 2159-2165
59. Miyano T., and Manabe N. Oocyte growth and acquisition of meiotic competence. Soc. Reprod. Fertil. Suppl. 63 (2007) 531-538
60. Montanelli L., Delbaere A., Di Carlo C., Nappi C., Smits G., Vassart G., and Costagliola S. A mutation in the follicle-stimulating hormone receptor as a cause of familial spontaneous ovarian hyperstimulation syndrome. J. Clin. Endocrinol. Metab. 89 (2004) 1255-1258
61. Montgomery G.W., Duffy D.L., Hall J., Kudo M., Martin N.G., and Hsueh A.J. Mutations in the follicle-stimulating hormone receptor and familial dizygotic twinning. Lancet 357 (2001) 773-774
62. Moyle W.R., Campbell R.K., Myers R.V., Bernard M.P., Han Y., and Wang X. Co-evolution of ligand-receptor pairs. Nature 368 (1994) 251-255
63. Nappi R.G., Di Naro E., D'Aries A.P., and Nappi L. Natural pregnancy in hypothyroid woman complicated by spontaneous ovarian hyperstimulation syndrome. Am. J. Obstet. Gynecol. 178 (1998) 610-611
64. O'Shaughnessy P.J., Bennett M.K., Scott I.S., and Charlton H.M. Effects of FSH on Leydig cell morphology and function in the hypogonadal mouse. J. Endocrinol. 135 (1992) 517-525
65. Palczewski K., Kumasaka T., Hori T., Behnke C.A., Motoshima H., Fox B.A., Le Trong I., Teller D.C., Okada T., Stenkamp R.E., Yamamoto M., and Miyano M. Crystal structure of rhodopsin: a G protein-coupled receptor. Science 289 (2000) 739-745
66. Perez Mayorga M., Gromoll J., Behre H.M., Gassner C., Nieschlag E., and Simoni M. Ovarian response to follicle-stimulating hormone (FSH) stimulation depends on the FSH receptor genotype. J. Clin. Endocrinol. Metab. 85 (2000) 3365-3369
67. Phillip M., Arbelle J.E., Segev Y., and Parvari R. Male hypogonadism due to a mutation in the gene for the beta-subunit of follicle-stimulating hormone. N. Engl. J. Med. 338 (1998) 1729-1732
68. Poirot C., Vacher-Lavenu M.C., Helardot P., Guibert J., Brugieres L., and Jouannet P. Human ovarian tissue cryopreservation: indications and feasibility. Hum. Reprod. 17 (2002) 1447-1452
69. Quellari M., Desroches A., Beau I., Beaudeux E., and Misrahi M. Role of cleavage and shedding in human thyrotropin receptor function and trafficking. Eur. J. Biochem. 270 (2003) 3486-3497
70. Rannikko A., Pakarinen P., Manna P.R., Beau I., Misrahi M., Aittomaki K., and Huhtaniemi I. Functional characterization of the human FSH receptor with an inactivating Ala189Val mutation. Mol. Hum. Reprod. 8 (2002) 311-317
71. Rodien P., Bremont C., Sanson M.L., Parma J., Van Sande J., Costagliola S., Luton J.P., Vassart G., and Duprez L. Familial gestational hyperthyroidism caused by a mutant thyrotropin receptor hypersensitive to human chorionic gonadotropin. N. Engl. J. Med. 339 (1998) 1823-1826
72. Schnorr Jr. J.A., Miller H., Davis J.R., Hatch K., and Seeds J. Hyperreactio luteinalis associated with pregnancy: a case report and review of the literature. Am. J. Perinatol. 13 (1996) 95-97
73. Smits G., Campillo M., Govaerts C., Janssens V., Richter C., Vassart G., Pardo L., and Costagliola S. Glycoprotein hormone receptors: determinants in leucine-rich repeats responsible for ligand specificity. EMBO J. 22 (2003) 2692-2703
74. Sudo S., Kudo M., Wada S., Sato O., Hsueh A.J., and Fujimoto S. Genetic and functional analyses of polymorphisms in the human FSH receptor gene. Mol. Hum. Reprod. 8 (2002) 893-899
75. Sundblad V., Chiauzzi V.A., Escobar M.E., Dain L., and Charreau E.H. Screening of FSH receptor gene in Argentine women with premature ovarian failure (POF). Mol. Cell. Endocrinol. 222 (2004) 53-59
76. Themmen A.P. An update of the pathophysiology of human gonadotrophin subunit and receptor gene mutations and polymorphisms. Reproduction 130 (2005) 263-274
77. Themmen A.P.N., and Huhtaniemi I.T. Mutations of gonadotropins and gonadotropin receptors: elucidating the physiology and pathophysiology of pituitary-gonadal function. Endocr. Rev. 21 (2000) 551-583
78. Touraine P., Beau I., Gougeon A., Meduri G., Desroches A., Pichard C., Detoeuf M., Paniel B., Prieur M., Zorn J.R., Milgrom E., Kuttenn F., and Misrahi M. New natural inactivating mutations of the follicle-stimulating hormone receptor: correlations between receptor function and phenotype. Mol. Endocrinol. 13 (1999) 1844-1854
79. Urizar E., Montanelli L., Loy T., Bonomi M., Swillens S., Gales C., Bouvier M., Smits G., Vassart G., and Costagliola S. Glycoprotein hormone receptors: link between receptor homodimerization and negative cooperativity. EMBO J. 24 (2005) 1954-1964
80. Vaskivuo T.E., Aittomaki K., Anttonen M., Ruokonen A., Herva R., Osawa Y., Heikinheimo M., Huhtaniemi I., and Tapanainen J.S. Effects of follicle-stimulating hormone (FSH) and human chorionic gonadotropin in individuals with an inactivating mutation of the FSH receptor. Fertil. Steril. 78 (2002) 108-113
81. Vassart G. Activating mutations of the TSH receptor. Thyroid 14 (2004) 86-87
82. Vassart G., Pardo L., and Costagliola S. A molecular dissection of the glycoprotein hormone receptors. Trends Biochem. Sci. 29 (2004) 119-126
83. Vasseur C., Rodien P., Beau I., Desroches A., Gerard C., de Poncheville L., Chaplot S., Savagner F., Croue A., Mathieu E., Lahlou N., Descamps P., and Misrahi M. A chorionic gonadotropin-sensitive mutation in the follicle-stimulating hormone receptor as a cause of familial gestational spontaneous ovarian hyperstimulation syndrome. N. Engl. J. Med. 349 (2003) 753-759
84. Vihko K.K., LaPolt P.S., Nishimori K., and Hsueh A.J. Stimulatory effects of recombinant follicle-stimulating hormone on Leydig cell function and spermatogenesis in immature hypophysectomized rats. Endocrinology 129 (1991) 1926-1932
85. Vlaeminck-Guillem V., Ho S.C., Rodien P., Vassart G., and Costagliola S. Activation of the cAMP pathway by the TSH receptor involves switching of the ectodomain from a tethered inverse agonist to an agonist. Mol. Endocrinol. 16 (2002) 736-746
86. Zalel Y., Orvieto R., Ben-Rafael Z., Homburg R., Fisher O., and Insler V. Recurrent spontaneous ovarian hyperstimulation syndrome associated with polycystic ovary syndrome. Gynecol. Endocrinol. 9 (1995) 313-315
87. Zeleznik A.J. The physiology of follicle selection. Reprod. Biol. Endocrinol. 2 (2004) 31
88. Zhang M., Tong K.P., Fremont V., Chen J., Narayan P., Puett D., Weintraub B.D., and Szkudlinski M.W. The extracellular domain suppresses constitutive activity of the transmembrane domain of the human TSH receptor: implications for hormone-receptor interaction and antagonist design. Endocrinology 141 (2000) 3514-3517